Preference-weighted health-related quality of life measures and substance use disorder severity

Addiction

Volumn 103, Issue 8, 2008, Pages 1320-1329

  Pyne, Jeffrey M ^a,b   French, Michael ^c   McCollister, Kathryn ^c   Tripathi, Shanti ^b   Rapp, Richard ^d   Booth, Brenda ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Cost effectiveness analysis; Cost utility analysis; Health related quality of life; Quality of wellbeing scale; SF 12 scale; Substance use disorder

Indexed keywords

ADDICTION SEVERITY INDEX; ADULT; ARTICLE; CHECKLIST; COST UTILITY ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EMPLOYMENT; FAMILY STRESS; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; QUALITY OF WELL BEING SCALE; SHORT FORM 12; SOCIAL PROBLEM; SUBSTANCE ABUSE; UNITED STATES; VALIDITY;

ADULT; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 47549118905     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2008.02153.x     Document Type: Article

References (61)

1. Sindelar J. L., Jofre-Bonet M., French M. T., Mclellan A. T. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes. Drug Alcohol Depend 2004 73 : 41 50.
2. Van Der Zanden B. P., Dijkgraaf M. G. W., Blanken P., De Borgie C. A., Van Ree J. M., Van Den Brink W. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population. Drug Alcohol Depend 2006 83 : 111 18.
3. Dijkgraaf M. G., Van Der Zanden B. P., De Borgie C. A., Blanken P., Van Ree J. M., Van Den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ 2005 330 : 1297 03.
4. Alcohol Treatment Trial (UKATT). Cost effectiveness of treatment for alcohol problems: findings of the randomized UK Alcohol Treatment Trial (UKATT). Br Med J 2005 7516 : 554 9.
5. Harris A. H., Godpodarevskaya E., Ritter A. J. A randomized trial of the cost effectivenss of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmaceconomics 2005 23 : 77 91.
6. Ahmad S. The cost-effectiveness of raising the legal smoking age in California. Med Decis Making 2005 25 : 330 40.
7. Ahmad S. Increasing excise taxes on cigarettes in California: a dynamic simulation of health and economic impacts. Prev Med 2005 41 : 276 83.
8. Ahmad S., Billimek J. Estimating the health impacts of tobacco harm reduction policies: a simulation modeling approach. Risk Anal 2005 25 : 801 12.
9. Emery S., Ake C. F., Navarro A. M., Kaplan R. M. Simulated effect of tobacco tax variation on Latino health in California. Am J Prev Med 2001 21 : 278 83.
10. Feenstra T. L., Hamberg-Van Reenen H. H., Kleinschmidt K., Schatz M., Weinknecht S., Kaplan R. M. Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease. Value Health 2005 8 : 178 90.
11. Johansson P. M., Tillgren P. E., Guldbrandsson K. A., Lindholm L. A. A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children. Scand J Public Health 2005 33 : 343 52.
12. Ong M. K., Glantz S. A. Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparision. Am J Public Health 2005 95 : 969 75.
13. Solberg L. I., Maciosek M. V., Edwards N. M., Khanchandani H. S., Goodman M. J. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness. Am J Public Health 2006 31 : 62 71.
14. Tengs T. O., Ahmad S., Savage J. M., Moore R., Gage E. The AMA proposal to mandate nicotine reduction in cigarettes: a simulation of the population health impacts. Preventive Med 2005 40 : 170 80.
15. Tengs T. O., Ahmad S., Moore R., Gage E. Federal policy mandating safer cigarettes: a hypothetical simulation of the anticipated population health gains or losses. J Policy Anal Manage 2004 23 : 857 72.
16. Tengs T. O., Osgood N. D., Chen L. L. The cost-effectiveness of intensive national school-based anti-tobacco education: results from the Tobacco Policy Model. Prev Med 2001 33 : 558 70.
17. Tengs T. O., Osgood N. D., Lin T. H. Public health impact of changes in smokig behavior: results from the Tobacco Policy Model. Med Care 2001 39 : 1131 41.
18. Wang L. Y., Crossett L. S., Lowry R., Sussman S., Dent C. W. Cost-effectiveness of a school-based tobacco-use prevention program. Arch Pediatr Adolesc Med 2001 155 : 1043 50.
19. Cromwell J., Bartosch W. J., Fiore M. C., Hasselblad V., Baker T. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997 278 : 1759 66.
20. Barnett P. G., Hui S. S. The cost-effectiveness of methadone maintenance. Mt Sinai J Med 2000 67 : 365 74.
21. Barnett P. G., Zaric G. S., Brandeau M. L. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction 2001 96 : 1267 78.
22. Zaric G. S., Barnett P. G., Brandeau M. L. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Public Health 2000 90 : 1100 11.
23. Mortimer D., Segal L. Economic evaluation of interventions for problem drinking and alcohol dependence: cost per QALY estimates. Alcohol Alcohol 2005 40 : 549 55.
24. Mortimer D., Segal L. Economic evaluation of interventions for problem drinking and alcohol dependence: do within-family extenal effects make a difference? Alcohol Alcohol 2005 41 : 92 8.
25. World Health Organization (WHO). Constitution of The World Health Organization. WHO Basic Documents. Geneva : WHO 1948.
26. Gold M. R., Siegel J. E., Russell L. B., Weinstein M. C. Cost-effectiveness in health and medicine. New York : Oxford University Press, Inc. 1996, p. 425.
27. Kaplan R., Bush J., Berry C. Health status: types of validity and the index of well-being. Health Serv Res 1976 11 : 478 507.
28. Kaplan R., Ganiats T., Rosen P., Sieber W., Anderson J. Development of a self-administered Quality of Well-Being scale (QWB-SA): initial studies. Qual Life Res 1995 4 : 443 9.
29. Torrance G. W., Furlong W., Feeny D., Boyle M. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995 7 : 503 20.
30. Euroqol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990 16 : 199 208.
31. Hawthorne G., Richardson J., Osborne R. The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999 8 : 209 24.
32. Brazier J., Usherwood T., Harper R., Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998 51 : 1115 28.
33. Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002 21 : 271 92.
34. National Institute for Clinical Excellence. Guide to the methods of technology appraisal. 2004. Available at: http://www.nice.org.uk/niceMedia/pdf/ TAP_Methods.pdf (accessed 2 January 2008).
35. Kaplan R. Hippocratic Predicament: Affordability, Access, and Accountability in Health Care. San Diego : Academic Press 1993.
36. American Psychiatric A. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR). Washington, DC : American Psychiatric Association 2000.
37. Mclellan A. T., Kushner H., Metzger D., Peters R., Smith I., Grissom G. et al. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992 9 : 199 213.
38. Ware J. Kosinski M., Keller S. D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996 34 : 220 33.
39. Drummond M. F., O'Brien B., Stoddart G. L., Torrance G. W. Methods for the Economic Evaluation of Health Care Programmes. New York : Oxford University Press 1997.
40. Kaplan R. M., Sieber W. J., Ganiats T. G. The Quality of Well-Being Scale: comparison of the interviewer-administered version with the self-administered questionnaire. Psychol Health 1997 12 : 783 91.
41. Andresen E. M., Rothenberg B. M., Kaplan R. M. Performance of a self-administered mailed version of the Quality of Well-Being (QWB-SA) questionnaire among older adults. Med Care 1998 36 : 1349 60.
42. Sieber W. J., David K. M., Adams J. E., Kaplan R. M., Ganiats T. G. Assessing the impact of migraine on health-related quality of life: an additional use of the quality of well-being scale-self-administered. Headache 2000 40 : 662 71.
43. Pyne J. M., Sieber W. J., David K., Kaplan R. M., Rapaport M. H., Williams D. K. Use of the Quality of Well-Being self-administered version (QWB-SA) in assessing health-related quality of life in depression patients. J Affect Disord 2003 76 : 237 47.
44. Pyne J. M., Sullivan G., Kaplan R., Williams D. K. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. Med Care 2003 41 : 208 17.
45. Pyne J. M., Patterson T. L., Kaplan R. M., Gillin J. C., Koch W. L., Grant I. Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997 48 : 224 30.
46. Patterson T. L., Kaplan R. M., Grant I., Semple S. J., Moscona S., Koch W. L. et al. Quality of well-being in late-life psychosis. Psychiatry Res 1996 63 : 169 81.
47. Beattie M. C., Hu T. W., Li R., Bond J. C. Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system. J Behav Health Serv Res 2005 32 : 409 29.
48. Frosch D., Porzsolt F., Heicappell R., Kleinschmidt K., Schatz M., Weinknecht S. et al. Comparison of German language versions of the QWB-SA and SF-36 evaluating outcomes for patients with prostate disease. Qual Life Res 2001 10 : 165 73.
49. Frosch D. L., Kaplan R. M., Ganiats T. G., Groessl E. J., Sieber W. J., Weisman M. H. Validity of self-administered quality of well-being scale in musculoskeletal disease. Arthritis Rheum 2004 51 : 28 33.
50. Kaplan R., Rosen P., David K., Sieber W. Measuring outcomes of cataract surgery using the Quality of Well-Being scale and the VF-14. Qual Life Res 1999 8 : 639.
51. Kaplan R. M., Schmidt S. M., Cronan T. A. Quality of well being in patients with fibromyalgia. J Rheumatol 2000 27 : 1785 9.
52. Hanmer J., Lawrence W. F., Anderson J. P., Kaplan R. M., Fryback D. G. Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores. Med Decis Making 2006 26 : 391 400.
53. Pickard A. S., Wang Z., Walton S. M., Lee T. A. Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? Health Qual Life Outcomes 2005 3 : 11.
54. Brazier J., Roberts J., Tsuchiya A., Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004 13 : 873 84.
55. Laupacis A., Feeny D., Detsky A. S., Tugwell P. X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992 146 : 473 81.
56. Mclellan A. T., Lewis D. C., O'brien C. P., Kleber H. D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000 284 : 1689 95.
57. White M. C., Chafetz L., Collins-Bride G., Nickens J. History of arrest, incarceration and victimization in community-based severely mentally ill. J Commun Health 2006 31 : 123 35.
58. Patrick D. L., Sittampalam Y., Somerville S. M., Carter W. B., Bergner M. A cross-cultural comparison of health state values. Am J Public Health 1985 75 : 1402 7.
59. Hadorn D. C. The problem of discrimination in health care priority setting. JAMA 1992 268 : 1454 9.
60. Boyd N., Sutherland H., Heasman K., Al E. Whose utilities for decision analysis? Med Decis Making 1990 10 : 58 67.
61. Smith G., Burnam M. A., Mosley C., Hollenberg J., Mancino M., Grimes W. Reliability and validity of the substance abuse outcomes module. Psychiatr Serv 2006 57 : 1452 60.